This is a preview of subscription content, log in via an institution to check access.
References
Institute for Clinical and Economic Review. ICER Publishes Evidence Report on the Use of Siponimod to Treat Secondary Progressive Multiple Sclerosis. Internet Document : 2 May 2019. Available from: URL: https://icer-review.org/announcements/spms_evidence_report/
ICER. ICER's Evidence Report Finds Esketamine May Benefit Patients with Treatment-Resistant Depression but Exceeds Cost-Effectiveness Thresholds. Internet Document : 9 May 2019. Available from: URL: https://icer-review.org/announcements/trd-evidence-report/
Institute for Clinical and Economic Review. ICER Posts Draft Scoping Document for the Assessment of Treatments for Type 2 Diabetes. Internet Document : 2 May 2019. Available from: URL: https://icer-review.org/announcements/diabetes2019_draft_scope/
Institute for Clinical and Economic Review. ICER Seeks Public Input for 2020 Value Assessment Framework. Internet Document : 2 May 2019. Available from: URL: https://icer-review.org/announcements/icer-seeks-public-input-for-2020-value-assessment-framework/
Rights and permissions
About this article
Cite this article
May 2019 news from ICER. PharmacoEcon Outcomes News 828, 3 (2019). https://doi.org/10.1007/s40274-019-5877-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5877-7